First report of mobile colistin resistance gene mcr-1 in avian pathogenic Escherichia coli isolated from turkeys in the Gaza Strip, Palestine

Background and Aim: Colistin is used to treat avian pathogenic Escherichia coli (APEC), a microorganism that affects turkey meat production in the Gaza Strip and worldwide. However, the recent emergence of plasmid-borne mobile colistin resistance (mcr) genes in pathogenic E. coli strains is a serious antimicrobial resistance (AMR) challenge for both human and animal health. In December 2018, colistin was banned as a veterinary antimicrobial in the Gaza Strip. This study aimed to detect and track the prevalence of colistin-resistant APEC isolated from turkey flocks in the Gaza Strip. Materials and Methods: This study investigated 239 APEC isolates from turkey flocks in the Gaza Strip between October 2018 and December 2021 (at 6-month intervals). The colistin-resistant APEC strains were detected using the broth microdilution method. The mcr-1 gene was identified using a polymerase chain reaction. Results: The overall colistin resistance among the isolated APECs was 32.2% during the study period. The average resistance in the first interval was 37.5%, which significantly decreased to 9.3% in the last interval. Among the 77 phenotypically resistant isolates, 32.4% were positive for mcr-1. The average abundance of mcr-1 in the first interval was 66.6%, which decreased to 25% in the last interval. Conclusion: To the best of our knowledge, this is the first study reporting the presence of the mcr-1 gene among the APEC isolates from turkeys in the Gaza Strip. Banned veterinary use of colistin significantly decreased the percentage of resistant APEC isolates from turkeys in Gaza Strip. Further studies are needed to investigate other colistin resistance genes and track the emergence of AMR

Synthesis and properties of polyelectrolyte multilayered microcapsules reinforced smart coatings

The present research work focuses on the synthesis, characterization and properties of novel polyelectrolyte multilayered microcapsules used as smart additives in organic coatings for corrosion protection of steel parts. Urea formaldehyde microcapsules encapsulated with linalyl acetate (UFMCs), sensitive to mechanical stimulus, were synthesized by in situ emulsion polymerization technique. In the next step, dodecylamine, working as a pH stimulus corrosion inhibitor, was loaded into layers of polyelectrolyte molecules, polyethylenimine (PEI) and sulfonated polyether ether ketone (SPEEK). These were applied layer-by-layer over the microcapsules to form inhibitor containing multilayered urea formaldehyde microcapsules (MLUFMCs). In the next step, MLUFMCs (5.0 wt%) and UFMCs (5.0 wt%) were thoroughly dispersed into the epoxy resin and coated on cleaned steel. A comparison of the structural, thermal and anticorrosive properties indicates that coatings modified with multilayered capsules (PMLSCs) demonstrate good thermal stability, improved self-healing characteristics and higher corrosion resistance compared to the coating modified with urea formaldehyde microcapsules. The improved properties of PMLSCs can be attributed to efficient release of the encapsulated self-healing agent and corrosion inhibitor from the MLUFMCs. Therefore, epoxy coatings modified with the novel multilayered capsules may be attractive for corrosion protection of steel parts used in oil and gas and related industries.Other Information Published in: Journal of Materials Science License: https://creativecommons.org/licenses/by/4.0See article on publisher's website: http://dx.doi.org/10.1007/s10853-019-03761-9</p